ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

UCLA Makes Members Compete For Space In Jonsson Center

August 3, 1990

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009